Compare BCRX & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | CTS |
|---|---|---|
| Founded | 1986 | 1896 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 1995 | 1994 |
| Metric | BCRX | CTS |
|---|---|---|
| Price | $7.63 | $57.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | $20.55 | ★ $73.67 |
| AVG Volume (30 Days) | ★ 5.1M | 233.7K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.26% |
| EPS Growth | ★ 381.40 | 15.87 |
| EPS | N/A | ★ 1.87 |
| Revenue | $25,186,000.00 | ★ $541,318,000.00 |
| Revenue This Year | N/A | $7.20 |
| Revenue Next Year | $3.71 | $7.57 |
| P/E Ratio | ★ N/A | $33.11 |
| Revenue Growth | N/A | ★ 4.95 |
| 52 Week Low | $6.23 | $40.15 |
| 52 Week High | $11.22 | $69.55 |
| Indicator | BCRX | CTS |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 59.70 |
| Support Level | $7.95 | $55.29 |
| Resistance Level | $9.22 | $62.56 |
| Average True Range (ATR) | 0.33 | 1.94 |
| MACD | 0.08 | 0.84 |
| Stochastic Oscillator | 53.73 | 75.65 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.